Skip to main content

Envisioning is an emerging technology research institute and advisory.

LinkedInInstagramGitHub

2011 — 2026

research
  • Observatory
  • Newsletter
  • Methodology
  • Origins
  • Vocab
services
  • Signals Session
  • Bespoke Projects
  • Build Sessions
  • Use Cases
  • Readinessfree
  • Signals
  • Free scan↗free
impact
  • ANBIMAFuture of Brazilian Capital Markets
  • IEEECharting the Energy Transition
  • Horizon 2045Future of Human and Planetary Security
  • WKOTechnology Scanning for Austria
solutions
  • Innovation
  • Strategy
  • Consultants
  • Foresight
  • Associations
  • Governments
resources
  • Partners
  • Coding for Non-Coders
  • How We Work
  • Data Visualization
  • Multi-Model Method
  • FAQ
  • Security & Privacy
about
  • Manifesto
  • Community
  • Events
  • Support
  • Contact
ResearchServicesSignalsAbout
ResearchServicesSignalsAbout
  1. Home
  2. Research
  3. Aura
  4. Bio-Printed Skin Grafts

Bio-Printed Skin Grafts

Layer-by-layer bioprinting of living skin tissue for wound repair and cosmetic restoration
Back to AuraView interactive version

3D bioprinting platforms use layer-by-layer deposition of living cells, bioinks, and scaffold materials to create structured skin constructs with functional epidermis, dermis, and integrated vasculature. These systems precisely control cell placement and matrix composition, enabling the fabrication of skin grafts that match patient-specific thickness, pigmentation, and structural properties. Advanced printers can incorporate multiple cell types—keratinocytes, fibroblasts, melanocytes, and endothelial cells—along with growth factors and extracellular matrix components to create grafts that integrate naturally with surrounding tissue.

This innovation addresses critical limitations in traditional skin grafting, where donor site availability, scarring, and aesthetic mismatches constrain reconstructive and aesthetic procedures. By printing custom skin constructs, these platforms enable scarless healing, precise aesthetic matching, and potentially unlimited graft material. Companies like Organovo, 3D Bioprinting Solutions, and research institutions are advancing these technologies, with some systems already producing functional skin grafts for burn treatment and reconstructive surgery.

The technology is particularly significant for aesthetic applications, where printed skin could enable scar revision, wrinkle reduction, and even elective enhancement procedures. As the technology matures and regulatory pathways clear, bioprinted skin could transform both reconstructive and aesthetic dermatology. However, ensuring long-term viability, managing immune responses, and achieving regulatory approval remain challenges. The technology represents a convergence of tissue engineering and aesthetic medicine, but requires continued development to achieve the reliability and aesthetic outcomes needed for widespread clinical adoption.

TRL
4/9Formative
Impact
5/5
Investment
4/5
Category
hardware

Related Organizations

Poietis logo

Poietis

France · Company

95%

Uses laser-assisted bioprinting (LAB) to print living cells with single-cell resolution.

Developer
Wake Forest Institute for Regenerative Medicine logo
Wake Forest Institute for Regenerative Medicine

United States · University

95%

A premier research institute led by Dr. Anthony Atala, famous for printing bladders and developing the ITOP printer.

Researcher
BICO (formerly CELLINK)

Sweden · Company

90%

The market leader in bio-convergence, producing a wide range of 3D bioprinters and bio-inks for research.

Developer
Organovo

United States · Company

90%

A pioneer in bioprinting functional human tissues for drug discovery and development, specifically liver and kidney models.

Developer
ROKIT Healthcare logo
ROKIT Healthcare

South Korea · Company

90%

Develops the Dr. INVIVO 4D bioprinter series for organ regeneration and skin printing.

Developer
CollPlant Biotechnologies logo
CollPlant Biotechnologies

Israel · Company

85%

Develops rhCollagen bioinks and partners with 3D Systems to print breast implants and other tissue scaffolds.

Developer
CTIBiotech

France · Company

85%

Specializes in 3D bioprinting and predictive ex vivo models for dermocosmetics and personalized medicine.

Developer
T&R Biofab

South Korea · Company

85%

A Korean biomedical engineering company specializing in 3D bioprinting scaffolds and tissues.

Developer
Aspect Biosystems logo
Aspect Biosystems

Canada · Company

80%

Uses microfluidic 3D bioprinting technology to create bioprinted therapeutics, partnering with Novo Nordisk.

Developer

Supporting Evidence

Evidence data is not available for this technology yet.

Research this in Signals

Scan Bio-Printed Skin Grafts for yourself.

Signals turns a topic into a sourced research record you can inspect and rerun. Your first scan is free, and this one starts with Bio-Printed Skin Grafts already loaded, so edit it or scan as is.